thinkMolecular

Bengaluru, India Founded: 2020 • Age: 6 yrs
Offers AI-augmented simulations for target identification and lead optimization in drug discovery.

About thinkMolecular

thinkMolecular is a company based in Bengaluru (India) founded in 2020 by Ramesh Sistla. It operates as a B2B. The company has 1 employees. thinkMolecular offers products and services including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology. thinkMolecular operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

Key Metrics
  • Annual Revenue
    ₹2.13 Cr

    FY 2024 · +104% YoY

  • Net Profit
    ₹92.6 Lakh

    FY 2024 · 44% margin

  • EBITDA
    ₹1.26 Cr

    FY 2024 · 59% margin

  • Employee Count
    1

Products & Services of thinkMolecular

thinkMolecular offers a comprehensive portfolio of products and services, including Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.

Target Identification and Validation
Drug Discovery Service

Analyzes data to identify and validate drug targets for informed profiles.

Hit Generation
Drug Discovery Service

Screens compounds using CADD for identifying potential hits.

Lead Generation
Drug Discovery Service

Optimizes hits into leads via design and selectivity techniques.

Lead Optimization
Drug Discovery Service

Enhances leads focusing on activity, DMPK, and adverse event mitigation.

Chemical Biology
Drug Discovery Service

Designs experiments based on molecular structures for target issues.

Board of directors of Thinkmolecular Technologies Private Limited (thinkMolecular)

Thinkmolecular Technologies Private Limited is the primary company behind thinkMolecular. The board of Thinkmolecular Technologies Private Limited currently have 2 directors; the longest-serving is Ravi Shankar Sistla, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Ravi Shankar Sistla
DIN 02181717
Director01 Aug 20206 yrs 2 moThinkmolecular Technologies Private Limited
Ramesh Kumar Sistla
DIN 08818906
Managing Director01 Aug 20206 yrs 2 moThinkmolecular Technologies Private Limited

People of thinkMolecular

1 people are tracked at thinkMolecular (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Founder, Managing DirectorLeadership
Premium access

Complete people profiles for thinkMolecular

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of thinkMolecular

Figures of Thinkmolecular Technologies Private Limited, the primary company behind thinkMolecular, for FY 2024. Revenue was ₹2.13 Cr (+104% year on year). Net profit was ₹92.6 Lakh (44% margin). EBITDA was ₹1.26 Cr (59% margin). Revenue has grown at a compounded annual rate of +205% over three years.

  • ₹2.13 CrRevenue · FY 2024 · +104% YoY
  • ₹92.6 LakhNet profit · 44% margin
  • ₹1.26 CrEBITDA · 59% margin
  • ₹5 LakhPaid-up capital
  • +205%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Thinkmolecular Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for thinkMolecular

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of thinkMolecular

thinkMolecular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
owkin.com2016Paris, France$321.1M47
An agentic AI platform is developed for biomedical research insights.
formation.bio2016New York, United States$608M–
AI-powered drug discovery platform for various diseases
absci.com2011Vancouver, United States$227.56M256
AI-based technology is used for recombinant protein production in therapeutics.
bighatbio.com2019San Carlos, United States$148.41M–
Antibody therapies are developed through machine learning and synthetic biology.
predictive-oncology.com2002Eagan, United States$43M31
AI-based platform for cancer diagnostics and precision medicine is utilized.
benchsci.com2015Toronto, Canada$157.73M–
AI platform used for extracting antibody data from scientific papers.
xtalpi.com2014Cambridge, United States$783.5M33
AI-driven crystal structure prediction for pharmaceutical development is offered.
iambic.ai2019San Diego, United States$206.23M50
AI-driven drug discovery platform for the treatment of cancer
exscientia.com2012Oxford, United Kingdom$428.63M392
AI-driven drug discovery and precision medicine solutions are provided.
Premium access

Detailed competitors of thinkMolecular

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to thinkMolecular

10 companies that operate in the same segment as thinkMolecular (AI in Life Sciences), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provides AI solutions and services for research publishing and communication.
2001Mumbai, Maharashtra, India–USD 91.43 M1,025
High-performance computing research is conducted by BSC in Barcelona.
2005Barcelona, Catalonia, Spain–––
Scientific communications, localization, and AI services for researchers and publishers.
2000Mumbai, Maharashtra, India–USD 25.46 M243
Fullpower-AI is recognized as a leading AI-biosensing platform company.
2003Santa Cruz, California, United StatesUSD 25 M––
Drug candidates are optimized via machine learning-enhanced medicinal chemistry.
2020Durham, North Carolina, United StatesUSD 5.5 M––
Provides big data analytics solutions tailored for the life sciences sector.
2006Bengaluru, Karnataka, India–––
AI-powered drug intelligence platform for life science professionals
–Beijing, China–––
Resource and marketplace for lab tools, services, and research news.
2013Bengaluru, Karnataka, India–––
Live cell imaging solutions are delivered via an AI-based platform.
–Wilmington, Delaware, United States–––
PR agency offering AI-assisted communications and media services for biotech companies.
2023Singapore, Singapore–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about thinkMolecular

thinkMolecular was founded in 2020.

thinkMolecular is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

thinkMolecular has 1 employees.

The primary company behind thinkMolecular, Thinkmolecular Technologies Private Limited, reported revenue of β‚Ή2.13 Cr for FY 2024, up 104% year on year.

Think Molecular specializes in molecular simulations to advance drug discovery processes. They use AI and machine learning to analyze genomic and structural data for tasks like target identification, hit generation, and lead optimization. The company provides services such as chemical biology experiments and scientific due diligence, primarily targeting pharmaceutical entities. Based in India, they enable efficient decision-making through computational tools and consultations.

thinkMolecular's top competitors include Owkin, Formation Bio and XtalPi.

thinkMolecular offers Target Identification and Validation, Hit Generation, Lead Generation, Lead Optimization, and Chemical Biology.

thinkMolecular operates through Thinkmolecular Technologies Private Limited.

The legal entities of thinkMolecular currently have 2 directors, including Ravi Shankar Sistla, Ramesh Kumar Sistla.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available